Alzheimer's disease (AD) risk appears reduced by both NSAIDs and docosahexaenoic acid (DHA). Cognitive deficits in AD are correlated with synaptic deficits, while cognitive deficits in the transgenic mouse models can be rapidly reversed with anti-Abeta antibody or NSAIDs. These effects do not require reduction in insoluble Abeta levels, but may depend on effects on soluble oligomers. Soluble Abeta oligomer-induced LTP and memory deficits are blocked by NSAIDs, and this may be mediated by effects on a Rac-PAK pathway, since it is a known target of oligomer signaling. PAKs are downstream Rac effectors critical for synapse formation, so oligomer-induced defects in PAK signaling may cause synaptic defects in AD. Signaling through the PAK complex, required for synapse formation and survival, is also modulated by DHA. Aged Tg2576 mice were placed on a DHA-depleting """"""""BAD"""""""" diet with safflower oil as the major fatty acid. With no evidence for neuron or synaptophysin loss, DHA depletion increased oxidative damage, caspase-cleaved actin and deficits in PSD-95 and the dendritic spine actin-binding protein, drebrin. The effect was transgene-dependent, suggesting that the BAD diet is permissive for a selective APP transgene induced synaptic deficit. Only Tg(+) mice on BAD diet developed major deficits in mRNAs associated with postsynaptic function and memory, including PI3K and PAKS, a gene linked to mental retardation and severe cognitive deficits. We hypothesize that: 1) PAK and PI3-K deficits cause drebrin, PSD-95 and spine loss and cofilin/Hirano pathology and dendritic caspase activation in vitro and in vivo. 2) Adult onset PAK deficits cause cognitive deficits. 3) Chronic Abeta oligomers and DHA depletion limit PAK activation leading to drebrin loss and reduced formation of new spines and synapses in vitro. 4) AD brain has a defective PAK signaling complex related to cognitive deficits. We propose to test these hypotheses in Tg2576, in culture models and in AD brain, focusing on alterations in the PAK kinase signaling complex and sequelae. Understanding dietary fatty acid /Abeta-related PAK complex deficits and downstream synaptic defects will reveal a poorly studied overlap between cognitive deficits in mental retardation syndromes and AD with therapeutic implications. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG013741-07A2
Application #
7038740
Study Section
Neurodegeneration and Biology of Glia Study Section (NDBG)
Program Officer
Snyder, Stephen D
Project Start
1998-01-01
Project End
2011-08-31
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
7
Fiscal Year
2006
Total Cost
$258,300
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Ma, Qiu-Lan; Yang, Fusheng; Frautschy, Sally A et al. (2012) PAK in Alzheimer disease, Huntington disease and X-linked mental retardation. Cell Logist 2:117-125
Cole, Greg M; Ma, Qiu-Lan; Frautschy, Sally A (2010) Dietary fatty acids and the aging brain. Nutr Rev 68 Suppl 2:S102-11
Cole, Greg M; Frautschy, Sally A (2010) Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease. CNS Neurol Disord Drug Targets 9:140-8
Cole, Greg M; Ma, Qiu-Lan; Frautschy, Sally A (2009) Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids 81:213-21
Ma, Qiu-Lan; Galasko, Douglas R; Ringman, John M et al. (2009) Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol 66:448-57
Hu, Shuxin; Begum, Aynun N; Jones, Mychica R et al. (2009) GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiol Dis 33:193-206
Ma, Qiu-Lan; Yang, Fusheng; Rosario, Emily R et al. (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078-89
Kotilinek, Linda A; Westerman, Marcus A; Wang, Qinwen et al. (2008) Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain 131:651-64
Ma, Qiu-Lan; Yang, Fusheng; Calon, Frederic et al. (2008) p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis. J Biol Chem 283:14132-43
Ma, Qiu-Lan; Teter, Bruce; Ubeda, Oliver J et al. (2007) Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. J Neurosci 27:14299-307

Showing the most recent 10 out of 24 publications